The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for ...

CGRP (calcitonin gene-related peptide) is a molecule that plays a central role in migraine attacks. It dilates blood vessels ...

Key Takeaways New research shows CGRP-targeted therapies can help migraine sufferers These medications block a protein that ...

New CGRP-targeted migraine drugs reduce headache days with fewer side effects, offering safer, more effective treatment ...

Decreasing the number of migraine attacks and resolving each attack quickly when it occurs are more important than ever, according to an expert; the reason is that these strategies help prevent ...

Neurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the future of migraine research is headed. Standard treatments taken at the onset of a migraine episode ...

Researchers have found that a newer group of migraine medications may offer better relief and fewer side effects than many ...